"Treatment was successful in nearly nine out of every 10 patients in whom TEER was used to repair their mitral valve," said Raj Makkar, MD, Cedars-Sinai's vice president of Cardiovascular Innovation ...

PARIS -- Transcatheter mitral valve replacement (TMVR) could be the better choice over conservative therapy for secondary (or functional) mitral regurgitation (MR), according to researchers settling ...

A “minimalist” approach to transfemoral valve-in-valve transcatheter mitral valve replacement (TMVR), not unlike the approach commonly used with TAVI, appears to be safe and feasible when compared ...

In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved, but procedure-related morbidity remains a concern. A new study published today in the Journal of ...

Mortality at 30 days was deemed “acceptable” after valve-in-valve and valve-in-ring procedures, but “high” after valve-in-MAC ...

LOS GATOS, Calif., Oct. 23, 2024 /PRNewswire/ -- Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced today the first-in-human trans-septal implantations using the 28 Fr. (French) Luna™ ...

NEW YORK CITY -- Mitral valve technology developers were urged to go back to the drawing board due to current-generation devices not meeting the needs of enough patients with mitral regurgitation (MR) ...

Edwards Lifesciences recently exercised its option to acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement (TMVR) company. The company expects to pay about $300 million ...

Please provide your email address to receive an email when new articles are posted on . A meta-analysis suggests reduced risk for stroke with anticoagulant use after transcatheter mitral valve repair.

Abbott Laboratories has received approval for a mitral valve replacement that can be implanted without open-heart surgery. The U.S. Food & Drug Administration gave the OK for the North Chicago-based ...